E-LIB Suche - Ergebnisse für: Blay, J.-Y.

1

Novel trial designs for patients with gastrointestinal stro..:

Serrano, C. ; Rothschild, S. ; Villacampa, G....
ESMO Open. 9 (2024) 1 - p. 102218 , 2024

Link: https://doi.org/10.1016/..

2

Impact of artificial intelligence in transforming the docto..:

Heudel, P.-E. ; Crochet, H. ; Blay, J.-Y.
ESMO Real World Data and Digital Oncology. 3 (2024) - p. 100026 , 2024

Link: https://doi.org/10.1016/..

3

Policy strategies for capacity building and scale up of the..:

Trapani, D. ; Murthy, S.S. ; Hammad, N....
ESMO Open. 9 (2024) 4 - p. 102946 , 2024

Link: https://doi.org/10.1016/..

4

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology. 35 (2024) 4 - p. 351-363 , 2024

Link: https://doi.org/10.1016/..

5

Long term activity of vemurafenib in cancers with BRAF muta..:

Blay, J.Y. ; Cropet, C. ; Mansard, S....
ESMO Open. 8 (2023) 6 - p. 102038 , 2023

Link: https://doi.org/10.1016/..

6

Corrigendum to "SELNET clinical practice guidelines for sof..:

Blay, J.Y. ; Hindi, N. ; Bollard, J....
Cancer Treatment Reviews. 115 (2023) - p. 102523 , 2023

Link: https://doi.org/10.1016/..

7

Regorafenib in patients with relapsed advanced or metastati..:

Le Cesne, A. ; Chevreau, C. ; Perrin, C....
ESMO Open. 8 (2023) 3 - p. 101569 , 2023

Link: https://doi.org/10.1016/..

8

EE64 Change in Healthcare Resource Use and Associated Costs..:

Chouaid, C. ; Marchal, C. ; Apert, M....
Value in Health. 26 (2023) 12 - p. S62 , 2023

Link: https://doi.org/10.1016/..

9

Natural history and treatment efficacy in an ambispective c..:

Dufresne, A. ; Pissaloux, D. ; Ngo, C....
ESMO Open. 8 (2023) 2 - p. 101202 , 2023

Link: https://doi.org/10.1016/..

10

RWD12 Wayfind-R: A Global, Real-World Precision Oncology Re..:

Hackshaw, A. ; Dienstmann, R. ; Blay, J.Y....
Value in Health. 26 (2023) 12 - p. S506 , 2023

Link: https://doi.org/10.1016/..

11

Efficacy of immune checkpoint inhibitors in alveolar soft-p..:

Hindi, N. ; Razak, A. ; Rosenbaum, E....
ESMO Open. 8 (2023) 6 - p. 102045 , 2023

Link: https://doi.org/10.1016/..

12

Synovial sarcoma: characteristics, challenges, and evolving..:

Blay, J.-Y. ; von Mehren, M. ; Jones, R.L....
ESMO Open. 8 (2023) 5 - p. 101618 , 2023

Link: https://doi.org/10.1016/..

13

Reduced risk of secondary primary extra pulmonary cancer in..:

Heudel, P.E. ; de Montfort, A. ; Debieuvre, D....
Lung Cancer. 182 (2023) - p. 107280 , 2023

Link: https://doi.org/10.1016/..

14

Pembrolizumab in soft-tissue sarcomas with tertiary lymphoi..:

Italiano, A. ; Bessede, A. ; Pulido, M....
Nature Medicine. 28 (2022) 6 - p. 1199-1206 , 2022

Link: https://doi.org/10.1038/..

15

Patterns of care and outcomes of 417 patients with METAstat..:

Moreau-Bachelard, C. ; Campion, L. ; Toulmonde, M....
ESMO Open. 7 (2022) 2 - p. 100402 , 2022

Link: https://doi.org/10.1016/..